These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17850953)

  • 1. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders.
    Gonzalez-Rey E; Delgado M
    Mol Cell Endocrinol; 2008 May; 286(1-2):135-40. PubMed ID: 17850953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keeping the balance between immune tolerance and pathogen immunity with endogenous neuropeptides.
    Gonzalez-Rey E
    Neuroimmunomodulation; 2010; 17(3):161-4. PubMed ID: 20134192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptides as pleiotropic modulators of the immune response.
    Souza-Moreira L; Campos-Salinas J; Caro M; Gonzalez-Rey E
    Neuroendocrinology; 2011; 94(2):89-100. PubMed ID: 21734355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortistatin as a potential multistep therapeutic agent for inflammatory disorders.
    Gonzalez-Rey E; Delgado M
    Drug News Perspect; 2006 Sep; 19(7):393-9. PubMed ID: 17080202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?
    Gonzalez-Rey E; Delgado M
    Trends Pharmacol Sci; 2007 Sep; 28(9):482-91. PubMed ID: 17688953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.
    Gonzalez-Rey E; Anderson P; Delgado M
    Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii70-6. PubMed ID: 17934101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation.
    Leceta J; Gomariz RP; Martinez C; Carrión M; Arranz A; Juarranz Y
    Neuroimmunomodulation; 2007; 14(3-4):134-8. PubMed ID: 18073504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cortistatin in the human immune system.
    van Hagen PM; Dalm VA; Staal F; Hofland LJ
    Mol Cell Endocrinol; 2008 May; 286(1-2):141-7. PubMed ID: 18450367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.
    Anderson P; Delgado M
    J Cell Mol Med; 2008 Oct; 12(5B):1830-47. PubMed ID: 18554314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents.
    Delgado M; Ganea D
    Brain Behav Immun; 2008 Nov; 22(8):1146-51. PubMed ID: 18598752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders.
    Pozo D; Gonzalez-Rey E; Chorny A; Anderson P; Varela N; Delgado M
    Peptides; 2007 Sep; 28(9):1833-46. PubMed ID: 17521775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
    Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
    J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.
    Ferone D; Boschetti M; Resmini E; Giusti M; Albanese V; Goglia U; Albertelli M; Vera L; Bianchi F; Minuto F
    Ann N Y Acad Sci; 2006 Jun; 1069():129-44. PubMed ID: 16855140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?
    Staines DR
    Med Hypotheses; 2004; 62(5):646-52. PubMed ID: 15082083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides as therapeutic approach to autoimmune diseases.
    Gonzalez-Rey E; Delgado-Maroto V; Souza Moreira L; Delgado M
    Curr Pharm Des; 2010; 16(28):3158-72. PubMed ID: 20687881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis.
    Gonzalez-Rey E; Delgado M
    Trends Mol Med; 2007 Jun; 13(6):241-51. PubMed ID: 17467339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of immune tolerance by anti-inflammatory neuropeptides.
    Gonzalez-Rey E; Chorny A; Delgado M
    Nat Rev Immunol; 2007 Jan; 7(1):52-63. PubMed ID: 17186031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-neuroendocrine interactions and autoimmune diseases.
    Jara LJ; Navarro C; Medina G; Vera-Lastra O; Blanco F
    Clin Dev Immunol; 2006; 13(2-4):109-23. PubMed ID: 17162354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning inflammation with anti-inflammatory neuropeptides.
    Varela N; Chorny A; Gonzalez-Rey E; Delgado M
    Expert Opin Biol Ther; 2007 Apr; 7(4):461-78. PubMed ID: 17373898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead.
    Gahete MD; Durán-Prado M; Luque RM; Martínez-Fuentes AJ; Vázquez-Martínez R; Malagón MM; Castaño JP
    Mol Cell Endocrinol; 2008 May; 286(1-2):128-34. PubMed ID: 18215456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.